DNTH
Price
$106.20
Change
+$2.92 (+2.83%)
Updated
Sep 11 closing price
Capitalization
5.94B
54 days until earnings call
Intraday BUY SELL Signals
EDIT
Price
$2.70
Change
+$0.05 (+1.89%)
Updated
Sep 11 closing price
Capitalization
416.97M
58 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DNTH vs EDIT

DNTH vs EDIT Comparison Chart in %
View a ticker or compare two or three
VS
DNTH vs. EDIT commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNTH is a Hold and EDIT is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNTH($5.94B) has a higher market cap than EDIT($417M). DNTH YTD gains are higher at: 157.704 vs. EDIT (31.707). EDIT has higher annual earnings (EBITDA): -67.46M vs. DNTH (-217.46M). DNTH has more cash in the bank: 887M vs. EDIT (212M). DNTH has less debt than EDIT: DNTH (1.29M) vs EDIT (15.5M). EDIT has higher revenues than DNTH: EDIT (47M) vs DNTH (1.9M).
DNTHEDITDNTH / EDIT
Capitalization5.94B417M1,424%
EBITDA-217.46M-67.46M322%
Gain YTD157.70431.707497%
P/E Ratio3.24N/A-
Revenue1.9M47M4%
Total Cash887M212M418%
Total Debt1.29M15.5M8%
FUNDAMENTALS RATINGS
DNTH vs EDIT: Fundamental Ratings
DNTH
EDIT
OUTLOOK RATING
1..100
7227
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
34
Fair valued
PROFIT vs RISK RATING
1..100
2100
SMR RATING
1..100
9699
PRICE GROWTH RATING
1..100
3656
P/E GROWTH RATING
1..100
55100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EDIT's Valuation (34) in the Biotechnology industry is somewhat better than the same rating for DNTH (83) in the null industry. This means that EDIT’s stock grew somewhat faster than DNTH’s over the last 12 months.

DNTH's Profit vs Risk Rating (2) in the null industry is significantly better than the same rating for EDIT (100) in the Biotechnology industry. This means that DNTH’s stock grew significantly faster than EDIT’s over the last 12 months.

DNTH's SMR Rating (96) in the null industry is in the same range as EDIT (99) in the Biotechnology industry. This means that DNTH’s stock grew similarly to EDIT’s over the last 12 months.

DNTH's Price Growth Rating (36) in the null industry is in the same range as EDIT (56) in the Biotechnology industry. This means that DNTH’s stock grew similarly to EDIT’s over the last 12 months.

DNTH's P/E Growth Rating (55) in the null industry is somewhat better than the same rating for EDIT (100) in the Biotechnology industry. This means that DNTH’s stock grew somewhat faster than EDIT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DNTHEDIT
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 11 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (DNTH: $106.20 vs. EDIT: $2.70)
Brand notoriety: DNTH and EDIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNTH: 97% vs. EDIT: 121%
Market capitalization -- DNTH: $5.94B vs. EDIT: $416.97M
DNTH [@Biotechnology] is valued at $5.94B. EDIT’s [@Biotechnology] market capitalization is $416.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNTH’s FA Score shows that 1 FA rating(s) are green while EDIT’s FA Score has 0 green FA rating(s).

  • DNTH’s FA Score: 1 green, 4 red.
  • EDIT’s FA Score: 0 green, 5 red.
According to our system of comparison, DNTH is a better buy in the long-term than EDIT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNTH’s TA Score shows that 5 TA indicator(s) are bullish while EDIT’s TA Score has 4 bullish TA indicator(s).

  • DNTH’s TA Score: 5 bullish, 3 bearish.
  • EDIT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, DNTH is a better buy in the short-term than EDIT.

Price Growth

DNTH (@Biotechnology) experienced а -1.76% price change this week, while EDIT (@Biotechnology) price change was -16.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

DNTH is expected to report earnings on Nov 05, 2026.

EDIT is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
DNTH
Daily Signal:
Gain/Loss:
EDIT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MIDU65.331.42
+2.22%
Direxion Daily Mid Cap Bull 3X ETF
SMHX56.691.10
+1.97%
VanEck Fabless Semiconductor ETF
SCHX30.110.25
+0.84%
Schwab US Large-Cap ETF™
JHMD45.850.34
+0.75%
JHancock Multifactor Developed Intl ETF
REK16.02-0.15
-0.93%
ProShares Short Real Estate

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with XENE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
+2.83%
XENE - DNTH
46%
Loosely correlated
-0.26%
EDIT - DNTH
42%
Loosely correlated
+1.89%
REPL - DNTH
41%
Loosely correlated
-2.42%
CLDX - DNTH
40%
Loosely correlated
-3.15%
IMTX - DNTH
40%
Loosely correlated
+0.46%
More